Meta-Collaboration to Improve Decentralized Trial Excellence: Updates from the Collaboration Landscape

Organizations from pharma sponsors, site networks, technology and service providers, advocacy groups and regulatory authorities have been collaborating in various forums to address challenges related to decentralized trials and improving participant access to research.

Keeping track of the work of various initiatives is a challenge for many in the community, but critical to ensure redundancy is avoided. This forum will address the meta-collaboration of decentralized trials, including representation from many of the initiatives leading change in the field.

Together the panelists will share updates on the scope of their work in the field as well as where collaboration opportunities exist across the ecosystem. Clarifying boundaries and scope will be a critical theme, as will ensuring transparency and avoidance of redundancy.